Generation and detection of levuglandins and isolevuglandins in vitro and in vivo

Molecules

Volumn 16, Issue 7, 2011, Pages 5333-5348

  Zhang, Ming ^a   Li, Wei ^b   Li, Tao ^c  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b TEXAS A AND M UNIVERSITY   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Levuglandin; Oxidative injury; Polyunsaturated fatty acids

Indexed keywords

LEVUGLANDIN E2; PROSTAGLANDIN E;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; METABOLISM; REVIEW;

ANIMALS; HUMANS; MOLECULAR STRUCTURE; PROSTAGLANDINS E;

EID: 79960749809     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16075333     Document Type: Review

References (78)

1. Ames, B.N. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 1983, 221, 1256-1264.
2. Montine, T.J.; Neely, M.D.; Quinn, J.F.; Beal, M.F.; Markesbery, W.R.; Roberts, L.J.; Morrow, J.D. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic. Biol. Med. 2002, 33, 620-626. (Pubitemid 35245834)
3. Smith, M.A.; Perry, G.; Richey, P.L.; Sayre, L.M.; Anderson, V.E.; Beal, M.F.; Kowall, N. Oxidative damage in Alzheimer's. Nature 1996, 382, 120-121.
4. Davies, S.S.; Amarnath, V.; Montine, K.S.; Bernoud-Hubac, N.; Boutaud, O.; Montine, T.J.; Roberts, L.J., 2nd. Effects of reactive gamma-ketoaldehydes formed by the isoprostane pathway (isoketals) and cyclooxygenase pathway (levuglandins) on proteasome function. FASEB J. 2002, 16, 715-717.
5. Amarnath, V.; Valentine, W.M.; Amarnath, K.; Eng, M.A.; Graham, D.G. The mechanism of nucleophilic substitution of alkylpyrroles in the presence of oxygen. Chem. Res. Toxicol. 1994, 7, 56-61. (Pubitemid 24041603)
6. Roberts, L.J., 2nd.; Salomon, R.G.; Morrow, J.D.; Brame, C.J. New developments in the isoprostane pathway: Identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts. FASEB J. 1999, 13, 1157-1168. (Pubitemid 29300362)
7. Salomon, R.G.; Subbanagounder, G.; Singh, U.; O'Neil, J.; Hoff, H.F. Oxidation of low-density lipoproteins produces levuglandin-protein adducts. Chem. Res. Toxicol. 1997, 10, 750-759. (Pubitemid 27315107)
8. Salomon, R.G.; Sha, W.; Brame, C.; Kaur, K.; Subbanagounder, G.; O'Neil, J.; Hoff, H.F.; Roberts, L.J., 2nd. Protein adducts of iso[4]levuglandin E2, a product of the isoprostane pathway, in oxidized low density lipoprotein. J. Biol. Chem. 1999, 274, 20271-20280.
9. Poliakov, E.; Meer, S.G.; Roy, S.C.; Mesaros, C.; Salomon, R.G. Iso[7]LGD2-protein adducts are abundant in vivo and free radical-induced oxidation of an arachidonyl phospholipid generates this D series isolevuglandin in vitro. Chem. Res. Toxicol. 2004, 17, 613-622. (Pubitemid 38669518)
10. Salomon, R.G.; Subbanagounder, G.; O'Neil, J.; Kaur, K.; Smith, M.A.; Hoff, H.F.; Perry, G.; Monnier, V.M. Levuglandin E2-protein adducts in human plasma and vasculature. Chem. Res. Toxicol. 1997, 10, 536-545. (Pubitemid 27217210)
11. Salomon, R.G.; Batyreva, E.; Kaur, K.; Sprecher, D.L.; Schreiber, M.J.; Crabb, J.W.; Penn, M.S.; DiCorletoe, A.M.; Hazen, S.L.; Podrez, E.A. Isolevuglandin-protein adducts in humans: Products of free radical-induced lipid oxidation through the isoprostane pathway. Biochim. Biophys. Acta 2000, 1485, 225-235. (Pubitemid 30314739)
12. Morrow, J.D.; Harris, T.M.; Roberts, L.J., 2nd. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoids. Anal. Biochem. 1990 184 1-10. (Pubitemid 20029736)
13. Morrow, J.D.; Hill, K.E.; Burk, R.F.; Nammour, T.M.; Badr, K.F.; Roberts, L.J., 2nd. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA 1990, 87, 9383-9387. (Pubitemid 120030630)
14. Morrow, J.D.; Awad, J.A.; Boss, H.J.; Blair, I.A.; Roberts, L.J., 2nd. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. USA 992, 89, 10721-10725.
15. Awad, J.A.; Morrow, J.D.; Takahashi, K.; Roberts, L.J., 2nd. Identification of non-cyclooxygenase -derived prostanoid (F2-isoprostane) metabolites in human urine and plasma. J. Biol. Chem. 1993, 268, 4161-4169. (Pubitemid 23072955)
16. Poliakov, E.; Brennan, M.L.; Macpherson, J.; Zhang, R.; Sha, W.; Narine, L.; Salomon, R.G.; Hazen, S.L. Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo. FASEB J. 2003, 17, 2209-2220. (Pubitemid 37509577)
17. Hamberg, M.; Samuelsson, B. Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc. Natl. Acad. Sci. USA 1973, 70, 899-903.
18. Ramwell, P.W.; Leovey, E.M.; Sintetos, A.L. Regulation of the arachidonic acid cascade. Biol. Reprod. 1977, 16, 70-87. (Pubitemid 8024236)
19. Nugteren, D.H.; Hazelhof, E. Isolation and properties of intermediates in prostaglandin biosynthesis. Biochim. Biophys. Acta 1973, 326, 448-461.
20. Samuelsson, B. From studies of biochemical mechanism to novel biological mediators: Prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982. Angew. Chem. Int. Ed. Engl. 1983, 22, 805-815.
21. Hamberg, M.; Svensson, J.; Wakabayashi, T.; Samuelsson, B. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc. Natl. Acad. Sci. USA 1974, 71, 345-349.
22. Bhagwat, S.S.; Hamann, P.R.; Still, W.C.; Bunting, S.; Fitzpatrick, F.A. Synthesis and structure of the platelet aggregation factor thromboxane A2. Nature 1985, 315, 511-513. (Pubitemid 15232871)
23. Bunting, S.; Gryglewski, R.; Moncada, S.; Vane, J.R. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and celiac ateries and inhibits platelet aggregation. Prostaglandins 1976, 12, 897-913. (Pubitemid 8015243)
24. Gryglewski, R.J.; Bunting, S.; Moncada, S.; Flower, R.J.; Vane, J.R. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins 1976, 12, 685-713.
25. Hamberg, M.; Svensson, J.; Samuelsson, B. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl. Acad. Sci. USA 1975, 72, 2994-2998.
26. Moncada, S.; Gryglewski, R.; Bunting, S.; Vane, J.R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976, 263, 663-665.
27. Whittaker, N.; Bunting, S.; Salmon, J.; Moncada, S.; Vane, J.R.; Johnson, R.A.; Morton, D.R.; Kinner, J.H.; Gorman, R.R.; McGuire, J.C.; et al. The chemical structure of prostaglandin X (prostacyclin). Prostaglandins 1976, 12, 915-928.
28. Coughlin, D.J.; Salomon, R.G. Synthesis and thermal reactivity of some 2,3-dioxabicyclo[2.2.1] heptane models of prostaglandin endoperoxides. J. Am. Chem. Soc. 1977, 99, 655-657. (Pubitemid 8102941)
29. Salomon, R.G.; Salomon, M.F. 2,3-Dioxabicyclo[2.2.1]heptane-strained bicyclic peroxide nucleus of prostaglandin endoperoxides. J. Am. Chem. Soc. 1977, 99, 3501-3503.
30. Zagorski, M.G.; Salomon, R.G. Prostaglandin endoperoxides. 11. Mechanism of amine-catalyzed fragmentation of 2,3-dioxabicyclo[2.2.1]heptane. J. Am. Chem. Soc. 1980, 102, 2501-2503.
31. Zagorski, M.G.; Salomon, R.G. Prostaglandin endoperoxides. 12. Carboxylate catalysis and the effects of proton donors on the decomposition of 2,3-dioxabicyclo[2.2.1]heptane. J. Am. Chem. Soc. 1982, 104, 3498-3503. (Pubitemid 12027711)
32. Iyer, R.S.; Miller, D.B.; Salomon, R.G. Prostaglandin endoperoxides. 26. Decomposition of levuglandin-E2-dehydration and allylic rearrangement products. J. Org. Chem. 1990, 55, 3175-3180. (Pubitemid 20197851)
33. Salomon, R.G.; Miller, D.B.; Raychaudhuri, S.R.; Avasthi, K.; Lal, K.; Levison, B.S. Prostaglandin endoperoxides. 15. Asymmetric total synthesis of levuglandin E2. J. Am. Chem. Soc. 1984, 106, 8296-8298. (Pubitemid 15189574)
34. Nugteren, D.H.; Vonkeman, H.; Vandorp, D.A. Non-enzymic conversion of all-cis 8,11,14- eicosatrienoic acid into prostaglandin E1. Recueil des Travaux Chimiques des Pays-Bas 1967, 86, 1237-1245.
35. Morrow, J.D.; Minton, T.A.; Mukundan, C.R.; Campbell, M.D.; Zackert, W.E.; Daniel, V.C.; Badr, K.F.; Blair, I.A.; Roberts, L.J. Free radical-induced generation of isoprostanes in-vivo- Evidence for the formation of D-ring and E-ring isoprostanes. J. Biol. Chem. 1994, 269, 4317-4326.
36. Morrow, J.D.; Awad, J.A.; Wu, A.P.; Zackert, W.E.; Daniel, V.C.; Roberts, L.J. Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo. J. Biol. Chem. 1996, 271, 23185-23190. (Pubitemid 26314756)
37. Salomon, R.G. Prostaglandin endoperoxide reaction-mechanisms and the discovery of levuglandins. Acc. Chem. Res. 1985, 18, 294-301.
38. Hobbs, H.H.; Russell, D.W.; Brown, M.S.; Goldstein, J.L. The LDL receptor locus in familial hypercholesterolemia: Mutational analysis of a membrane protein. Annu. Rev. Genet. 1990, 24, 133-170. (Pubitemid 120011544)
39. Bernoud-Hubac, N.; Davies, S.S.; Boutaud, O.; Montine, T.J.; Roberts, L.J., 2nd. Formation of highly reactive gamma-ketoaldehydes (neuroketals) as products of the neuroprostane pathway. J. Biol. Chem. 2001, 276, 30964-30970.
40. Zhang, R.L.; Brennan, M.L.; Shen, Z.Z.; MacPherson, J.C.; Schmitt, D.; Molenda, C.E.; Hazen, S.L. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J. Biol. Chem. 2002, 277, 46116-46122. (Pubitemid 35417600)
41. Klebanoff, S.J.; Clark, R.A. The Neutrophil: Function and Clinical Disorders; North Holland Biomedical Press: Amsterdam, The Netherlands, 1978.
42. Daugherty, A.; Dunn, J.L.; Rateri, D.L.; Heinecke, J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 1994, 94, 437-444. (Pubitemid 24218123)
43. Hazell, L.J.; Arnold, L.; Flowers, D.; Waeg, G.; Malle, E.; Stocker, R. Presence of hypochloritemodified proteins in human atherosclerotic lesions. J. Clin. Invest. 1996, 97, 1535-1544. (Pubitemid 26097044)
44. Hazen, S.L.; Heinecke, J.W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 1997, 99, 2075-2081. (Pubitemid 27203762)
45. Harrison, J.E.; Schultz, J. Studies on the chlorinating activity of myeloperoxidase. J. Biol. Chem. 1976, 251, 1371-1374.
46. Heinecke, J.W.; Li, W.; Daehnke, H.L., 3rd.; Goldstein, J.A. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J. Biol. Chem. 1993, 268, 4069-4077. (Pubitemid 23072943)
47. Brennan, M.L.; Wu, W.; Fu, X.; Shen, Z.; Song, W.; Frost, H.; Vadseth, C.; Narine, L.; Lenkiewicz, E.; Borchers, M.T.; et al. A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidasedeficient mice, and the nature of peroxidase-generated reactive nitrogen species. J. Biol. Chem. 2002, 277, 17415-17427. (Pubitemid 34967541)
48. van der Vliet, A.; Eiserich, J.P.; Halliwell, B.; Cross, C.E. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J. Biol. Chem. 1997, 272, 7617-7625. (Pubitemid 27137309)
49. Carr, A.C.; McCall, M.R.; Frei, B. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 1716-1723. (Pubitemid 30470585)
50. Podrez, E.A.; Abu-Soud, H.M.; Hazen, S.L. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic. Biol. Med. 2000, 28, 1717-1725. (Pubitemid 30628658)
51. Anderson, G.J.; Connor, W.E.; Corliss, J.D. Docosahexaenoic acid is the preferred dietary N-3 fatty-acid for the development of the brain and retina. Pediatr. Res. 1990, 27, 89-97. (Pubitemid 20023179)
52. Connor, W.E.; Neuringer, M.; Lin, D.S. Dietary effects on brain fatty acid composition: The reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys. J. Lipid Res. 1990, 31, 237-247. (Pubitemid 20089038)
53. Connor, W.E.; Neuringer, M.; Reisbick, S. Essential fatty-acids-The importance of N-3 fatty-acids in the retina and brain. Nutr. Rev. 1992, 50, 21-29.
54. Anderson, R.E.; Rapp, L.M.; Wiegand, R.D. Lipid-peroxidation and retinal degeneration. Curr. Eye Res. 1984, 3, 223-227.
55. Halliwell, B. Reactive oxygen species and the central-nervous-system. J. Neurochem. 1992, 59, 1609-1623.
56. Simonian, N.A.; Coyle, J.T. Oxidative stress in neurodegenerative diseases. Ann. Rev. Pharm. Toxicol. 1996, 36, 83-106. (Pubitemid 26168695)
57. Knight, J.A. Reactive oxygen species and the neurodegenerative disorders. Ann. Clin. Lab. Sci. 1997, 27, 11-25. (Pubitemid 27030199)
58. Markesbery, W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 1997, 23, 134-147. (Pubitemid 27217017)
59. Roberts, L.J.; Montine, T.J.; Markesbery, W.R.; Tapper, A.R.; Hardy, P.; Chemtob, S.; Dettbarn, W.D.; Morrow, J.D. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 1998, 273, 13605-13612. (Pubitemid 28268404)
60. Nourooz-Zadeh, J.; Liu, E.H.C.; Anggard, E.E.; Halliwell, B. F-4-isoprostanes: A novel class of prostanoids formed during peroxidation of docosahexaenoic acid (DHA). Biochem. Biophys. Res. Commun. 1998, 242, 338-344. (Pubitemid 28412429)
61. Salomon, R.G.; Miller, D.B.; Zagorski, M.G.; Coughlin, D.J. Solvent induced fragmentation of prostaglandin endoperoxides. New aldehyde products from PGH2 and a novel intramolecular 1,2-hydride shift during endoperoxide fragmentation in aqueous solution. J. Am. Chem. Soc. 1984, 106, 6049-6060. (Pubitemid 14012079)
62. Salomon, R.G.; Jirousek, M.R.; Ghosh, S.; Sharma, R.B. Prostaglandin endoperoxides 21. Covalent binding of levuglandin E2 with proteins. Prostaglandins 1987, 34, 643-656. (Pubitemid 18010592)
63. Brame, C.J.; Salomon, R.G.; Morrow, J.D.; Roberts, L.J., 2nd. Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts. J. Biol. Chem. 1999, 274, 13139-13146.
64. Boutaud, O.; Brame, C.J.; Salomon, R.G.; Roberts, L.J., 2nd.; Oates, J.A. Characterization of the lysyl adducts formed from prostaglandin H2 via the levuglandin pathway. Biochemistry 1999, 38, 9389-9396.
65. Iyer, R.S.; Kobierski, M.E.; Salomon, R.G. Generation of pyrroles in the reaction of levuglandin E2 with proteins. J. Org. Chem. 1994, 59, 6038-6043. (Pubitemid 24337016)
66. Bernoud-Hubac, N.; Fay, L.B.; Armarnath, V.; Guichardant, M.; Bacot, S.; Davies, S.S.; Roberts, L.J., 2nd.; Lagarde, M. Covalent binding of isoketals to ethanolamine phospholipids. Free Radic. Biol. Med. 2004, 37, 1604-1611. (Pubitemid 39349806)
67. Difranco, E.; Subbanagounder, G.; Kim, S.; Murthi, K.; Taneda, S.; Monnier, V.M.; Salomon, R.G. Formation and stability of pyrrole adducts in the reaction of levuglandin E(2) with proteins. Chem. Res. Toxicol. 1995, 8, 61-67.
68. Kobierski, M.E.; Kim, S.C.; Murthi, K.K.; Iyer, R.S.; Salomon, R.G. Synthesis of a pyrazole isostere of pyrroles formed by the reaction of the epsilon-amino groups of protein lysyl residues with levuglandin E(2). J. Org. Chem. 1994, 59, 6044-6050. (Pubitemid 24337017)
69. Davies, S.S.; Amarnath, V.; Roberts, L.J., 2nd. Isoketals: Highly reactive gamma-ketoaldehydes formed from the H2-isoprostane pathway. Chem. Phys. Lipids 2004, 128, 85-99. (Pubitemid 38167379)
70. Yamashita, M.; Fenn, J.B. Electrospray ion-source-Another variation on the free-jet theme. J. Phys. Chem. 1984, 88, 4451-4459.
71. Tanaka, K.; Waki, H.; Ido, Y.; Akita, S.; Yoshida, Y.; Yoshida, T.; Matsuo, T. Protein and polymer analyses up to m/z 100 000 by laser ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom 1988, 2, 151-153.
72. Karas, M.; Hillenkamp, F. Laser desorption ionization of proteins with molecular masses exceeding 10000 Daltons. Anal. Chem. 1988, 60, 2299-2301.
73. Domingues, M.R.M.; Reis, A.; Domingues, P. Mass spectrometry analysis of oxidized phospholipids. Chem. Phys. Lipids 2008, 156, 1-12.
74. Li, W. Oxidative modification of ethanolamine phospholipids by isolevuglandins: Detection by LC-MS/MS in vitro and in vivo. Ph.D. Thesis, Case Western Reserve University, Cleveland, OH, USA, 2009.
75. Brame, C.J.; Boutaud, O.; Davies, S.S.; Yang, T.; Oates, J.A.; Roden, D.; Roberts, L.J., 2nd. Modification of proteins by isoketal-containing oxidized phospholipids. J. Biol. Chem. 2004, 279, 13447-13451. (Pubitemid 38468868)
76. Boutaud, O.; Li, J.; Zagol, I.; Shipp, E.A.; Davies, S.S.; Roberts, L.J., 2nd.; Oates, J.A. Levuglandinyl adducts of proteins are formed via a prostaglandin H2 synthase-dependent pathway after platelet activation. J. Biol. Chem. 2003, 278, 16926-16928. (Pubitemid 36799565)
77. Li, W.; Laird, J.M.; Lu, L.; Roychowdhury, S.; Nagy, L.E.; Zhou, R.; Crabb, J.W.; Salomon, R.G. Isolevuglandins covalently modify phosphatidylethanolamines in vivo: Detection and quantitative analysis of hydroxylactam adducts. Free Radic. Biol. Med. 2009, 47, 1539-1552.
78. Roychowdhury, S.; McMullen, M.R.; Pritchard, M.T.; Li, W.; Salomon, R.G.; Nagy, L.E. Formation of gamma-ketoaldehyde-protein adducts during ethanol-induced liver injury in mice. Free Radic. Biol. Med. 2009, 47, 1526-1538.